The name is still too expensive to buy, Essaye said
The name is still too expensive to buy: Tom Essaye Quoted on Yahoo Finance
Palantir (PLTR) Is Called Too Expensive by Schwab Guests
Similarly, Essaye said that PLTR should be examined “in a context of reasonable valuation.” Although the shares are down a great deal from their highs, the name is still too expensive to buy, Essaye said. He added that the stock is being pressured by worries over the AI sector and fears about lower spending on contracts by Washington.
“Federal contracts are a large part of the company’s business,” Essaye noted.
Expressing his view of PLTR more bluntly, Essaye said that it “can continue to decline,” adding that it would have to drop a great deal more before he would “become interested” in it.
“It’s a good company, but it’s so richly valued that it can fall quite a bit more before value buyers step in,” he warned.
Also, click here to view the full article featured on Yahoo Finance published on April 1st, 2025. However, to see the Sevens Report’s full comments on the current market environment sign up here.
If you want research that comes with no long term commitment, yet provides independent, value added, plain English analysis of complex macro topics, then begin your Sevens Report subscription today by clicking here.
To strengthen your market knowledge take a free trial of The Sevens Report.
Join hundreds of advisors from huge brokerage firms like Morgan Stanley, Merrill Lynch, Wells Fargo Advisors, Raymond James, and more! To start your quarterly subscription and see how The Sevens Report can help you grow your business, click here.
